Solodyn® Prior Authorization CriteriaSUMMARYSolodyn has been approved by the Food and Drug Administration (FDA) for the treatment of inflammatorylesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older; it did notdemonstrate any effect on non-inflammatory ...
Arcalyst® Prior Authorization CriteriaAracalyst1Arcalyst (rilonacept) is an interleukin-1(IL-1) blocker indicated for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) including Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS) in adults and children 12 ...